Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,268 public trials 269 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Completed

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma

NCT02044120

Conditions
Ewing Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Seattle's Children Cancer Center Seattle, Washington, United States
View Trial Details
Completed

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

NCT01643850

Conditions
GCCTS, GCTS, Giant Cell Tumor of Tendon Sheath, +15 more
Locations
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site Denver, Colorado, United States
  • Novartis Investigative Site Washington D.C., District of Columbia, United States
  • Novartis Investigative Site Miami, Florida, United States
View Trial Details
Completed

Apatinib for Inoperable Advanced Chondrosarcoma

NCT04260113

Conditions
Chemically-Induced Disorders, Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions, +7 more
Locations
  • Musculoskeletal Tumor Center of Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking Univresity Shougang Hospital Beijing, Beijing Municipality, China
View Trial Details
Completed

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

NCT01338831

Conditions
Breast Diseases, Breast Neoplasms, Castration-resistant Prostate Cancer, +19 more
Locations
  • Massachusetts General Hospital Mass Gen 3 Boston, Massachusetts, United States
  • Cancer Institute of New Jersey SC New Brunswick, New Jersey, United States
  • Thomas Jefferson University, Dept. of Phsyciatry & Neurology Thomas Jefferson Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman 3 Salt Lake City, Utah, United States
View Trial Details
Completed

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

NCT01694277

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Institut Bergonié Bordeaux, France
  • Hôpital l'Archet 2- Service de Cancérologie Digestive Nice, France
  • Istituto per la Ricerca e la Cura del Cancro (IRCC) Candiolo, Italy
View Trial Details
Completed

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

NCT00135005

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Berlin, Germany
View Trial Details

Related conditions